Plasma proteomics-based biomarkers for predicting response to mesenchymal stem cell therapy in severe COVID-19

Plasma proteomics-based biomarkers for predicting response to mesenchymal stem cell therapy in severe COVID-19

Abstract Background The objective of this study was to identify potential biomarkers for predicting response to MSC therapy by pre-MSC treatment plasma proteomic profile in severe COVID-19 in order to optimize treatment choice. Methods A total of 58 patients selected from our previous RCT cohort wer...

Full description

Bibliographic Details
Main Authors: Tian-Tian Li, Wei-Qi Yao, Hai-Bo Dong, Ze-Rui Wang, Zi-Ying Zhang, Meng-Qi Yuan, Lei Shi, Fu-Sheng Wang
Format: Article
Language:English
Published: BMC 2023-12-01
Series:Stem Cell Research & Therapy
Subjects:
COVID-19
Mesenchymal stem cells
Proteomics
Predictive model
Online Access:https://doi.org/10.1186/s13287-023-03573-4

Internet

https://doi.org/10.1186/s13287-023-03573-4

Similar Items